• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Roche Holding AG Basel American Depositary Shares (OP: RHHBY )

    39.01 -0.42 (-1.07%)
    Streaming Delayed Price Updated: 9:31 AM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Roche Holding AG Basel American Depositary Shares

    < Previous 1 2
    ...
    17 18 19 20 21 22 23 24 25
    ...
    27 28 Next >
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! 
    Via InvestorPlace
    Atea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill
    Roche and Atea's partnership will end in February. 
    Via Investor's Business Daily
    Exposures Product Safety
    Tuesday Market Overview
    While gold gained modestly again today, cryptocurrencies fell hard. 
    Via Talk Markets
    Large Cap Biopharmaceuticals Metrics and Review: JNJ Splits Up
    Today JNJ announced a split of the Company separating its legacy consumer products from higher growth growing biopharmaceutical and medtech products. 
    Via Talk Markets
    Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
    The European Commission (EC) has approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) COVID-19 antibody cocktail, known as REGEN-COV in the U.S. and... 
    Via Benzinga
    Exposures COVID-19
    Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
    Johnson & Johnson will split its consumer health unit into a publicly traded company. 
    Via Investor's Business Daily
    The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded... 
    Via Benzinga
    Veteran's Day
    Stock markets took a tumble today across the board, but not as far down as at the opening. 
    Via Talk Markets
    EU Regulator Backs Regeneron-Roche's COVID-19 Drug
    The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Regeneron Pharmaceuticals Inc... 
    Via Benzinga
    Exposures COVID-19
    Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
    With already a snail-paced rollout of Biogen Inc's (NASDAQ: BIIB) controversial Alzheimer's treatment Aduhelm, the Company could soon face price competition.... 
    Via Benzinga
    ALX Oncology Falls After Updated Data For Solid Tumors Candidate
    ALX Oncology Holdings Inc (NASDAQ: ALXO) released additional data from a phase 1b trial of evorpacept in solid tumor malignancies. One cohort included gastric/... 
    Via Benzinga
    These OTCQX & OTCQB Securities Had the Most Trading Activity in October
    Photo by Burak Kebapci from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
    Via Benzinga
    Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
    Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has announced additional results from a Phase 3 trial, which assessed a single dose of REGEN-COV (1,200 mg... 
    Via Benzinga
    Exposures COVID-19
    The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
    Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
    Via Benzinga
    The Old Lady Of Threadneedle Street
    US markets are up on better jobs growth reported for October today. 
    Via Talk Markets
    Will Pfizer Outgun Merck With Oral COVID-19 Pill?
    Merck, Inc. (NYSE: MRK) is locking horns with peer Pfizer, Inc. (NYSE: PFE) in what could be termed as the battle supremacy in the COVID-19 treatment market. The stakes are high,... 
    Via Benzinga
    Exposures COVID-19
    Thursday Market Overview
    If you are an IBM shareholder you now own something new Kyndryl. 
    Via Talk Markets
    7 European Stocks to Buy to Diversify Your Portfolio
    While exposure to U.S.-based securities continues to be a good idea, you can diversify your opportunities by considering European stocks. 
    Via InvestorPlace
    Novartis To Offload Its Stake Back To Roche For $20.7B
    Novartis AG (NYSE: NVS), a shareholder in Roche Holdings AG (OTC: RHHBY) for more than 20 years, would sell its entire stake, which is nearly one-third voting... 
    Via Benzinga
    Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting
    Galecto Inc (NASDAQ: GLTO) has entered into a clinical trial supply agreement with Roche Holdings AG (OTC: RHHBY) to explore the combination of GB1211 in... 
    Via Benzinga
    Cyber Currency
    Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck. 
    Via Talk Markets
    Default Avoided
    The Chinese real estate firm Evergrande managed to pay the interest it owes to foreign bondholders. 
    Via Talk Markets
    Why Atea Pharmaceuticals Stock Got Crushed This Week
    A mid-stage trial miss caused investors to hit the exits this week. 
    Via The Motley Fool
    Exposures COVID-19
    FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)
    From Genentech
    Via Business Wire
    The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas... 
    Via Benzinga
    Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market
    Cortexyme is testing a twice-day pill to treat Alzheimer's disease. 
    Via Investor's Business Daily
    Wednesday Market Coverage
    Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal. 
    Via Talk Markets
    Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics
    Roche Holding AG (OTC: RHHBY) raised its 2021 sales forecast after posting an 8% rise in nine-month revenues, driven by demand for COVID-19 tests and the strong... 
    Via Benzinga
    Exposures COVID-19
    AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
    AstraZeneca Plc (NASDAQ: AZN) has paused an active Phase 1 trial of AZD5991, a direct inhibitor of MCL-1, citing a potential safety issue. Two years ago, the FDA hit ... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19... 
    Via Benzinga
    < Previous 1 2
    ...
    17 18 19 20 21 22 23 24 25
    ...
    27 28 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.